$12.74
-0.58-4.35%
Últ. Act.: Oct 29, 7:59 PM
Ginkgo Bioworks Holdings (DNA) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Ginkgo Bioworks Holdings (DNA) publicó su última previsión de noviembre 6, 2025 para fiscal year 2025. La compañía estimó ingresos en un rango de $167M - $187M para el período.
En comparación con la previsión anterior, Ginkgo Bioworks Holdings mantenido redujo su previsión de ingresos desde un rango anterior de $167M - $187M.
Ginkgo Bioworks Holdings ha emitido 13 actualizaciones de orientación entre el noviembre 14, 2022 y el noviembre 6, 2025. During this period, the company raised its outlook 2 times and lowered it 4 times, providing investors with insight into management's evolving expectations.
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.70 | $-1.34 | $-1.39 | $-1.24 |
| Actual | $-0.92 | $-1.39 | $-1.41 | $-1.45 |
| Surprise | -31.4% | -3.73% | -1.44% | -16.9% |
| Revenue | ||||
| Estimate | $24.8M | $42.4M | $37.3M | $39.0M |
| Actual | $20.2M | $19.5M | $33.3M | $38.8M |
| Surprise | -18.6% | -54.0% | -10.8% | -0.33% |
| Metric | Q3 '26E | Q4 '26E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $-0.55 | $-0.82 |
| Revenue | ||
| Consensus | $21.3M | $23.5M |
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q2 | Aug 5, 2026 | $-0.92 | $-0.70 | -31.4 % |
| Q1 | May 7, 2026 | $-1.39 | $-1.34 | -3.73 % |
| Q4 | Feb 26, 2026 | $-1.41 | $-1.39 | -1.44 % |
| Q3 | Nov 6, 2025 | $-1.45 | $-1.24 | -16.9 % |
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q2 | Aug 5, 2026 | $20.16M | $24.76M | -18.6 % |
| Q1 | May 7, 2026 | $19.47M | $42.37M | -54.0 % |
| Q4 | Feb 26, 2026 | $33.32M | $37.34M | -10.8 % |
| Q3 | Nov 6, 2025 | $38.84M | $38.97M | -0.33 % |